IL-6 and PD-L1 antibody blockade combination therapy reduces tumour progression in murine models of pancreatic cancerThomas A. Mace, Gregory B. Lesinski|Gut|2016Cited by 540
CD200 promotes immunosuppression in the pancreatic tumor microenvironmentFouad Choueiry, Thomas A. Mace|Journal for ImmunoTherapy of Cancer|2020Cited by 99
Soy isoflavones and their metabolites modulate cytokine-induced natural killer cell functionThomas A. Mace, Gregory B. Lesinski|Scientific Reports|2019Cited by 69
Tomatidine targets ATF4-dependent signaling and induces ferroptosis to limit pancreatic cancer progressionDebasmita Mukherjee, Thomas A. Mace|iScience|2023Cited by 34
Single agent BMS-911543 Jak2 inhibitor has distinct inhibitory effects on STAT5 signaling in genetically engineered mice with pancreatic cancerThomas A. Mace, Gregory B. Lesinski|Oncotarget|2015Cited by 16